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Each year, Jefferson surgeons perform 
over 200 pancreatic resections, 
including more than 130 “Whipple 
procedures” — making the hospital #1 
in surgical volume for pancreatic 
cancer and related diseases in the 
tristate region of Pennsylvania,  
New Jersey and Delaware.  
“While we are very proud of what  
we have achieved, there are always 
opportunities for improvement,” says 
Charles J. Yeo, MD, FACS, Samuel D. 
Gross Professor and Chair of Surgery, 
who has personally performed more 
than 1,400 Whipple procedures and 
treated thousands of patients with 
pancreatic cancer and related diseases. 
Beyond the impressive numbers, the 
Jefferson Pancreas, Biliary and Related 
Cancer Center offers much more: 
multidisciplinary diagnosis and 
treatment, groundbreaking clinical 
research, and active involvement in 
community events — such as Amy’s 
Ride/Run/Walk in Quakertown (May 
20) and Pancreatic Cancer Action 
Network’s PurpleStride (November 4). 
New Multidisciplinary Pancreatic 
Cancer Clinic
When pancreatic cancer is suspected, 
many patients and their families feel 
overwhelmed. In addition to the 
emotional impact, patients may have to 
schedule several appointments to see 
primary doctors and gastroenterologists, 
as well as surgeons, medical oncologists 
and radiation oncologists. At our 
Multidisciplinary Pancreatic Cancer 
Clinic, all relevant clinicians gather 
each Monday afternoon to review 
cases and see patients — providing 
the convenience of multiple 
appointments during a single visit.
Development of a National Cancer 
Institute Funded Research Program
Since his recruitment in 2006, 
Jonathan Brody, PhD, Vice Chair  
for Research in the Department of 
Surgery, has been building a world-
class pancreatic cancer research 
program. Dr. Brody specializes in 
studying the molecular basis of 
cancer development and progression, 
targeted therapy and personalized 
medicine. As a translational researcher, 
he steers the research trajectory of 
the Brody Laboratory while serving 
as an advisor/collaborator to all 
levels of trainees as well as our 
practicing surgeons, including Drs. 
Harish Lavu and Jordan Winter. 
Ongoing Clinical Trials
Harish Lavu, MD, FACS, is leading the 
Whipple Accelerated Recovery Pathway 
(WARP) trial aimed at supporting faster 
recovery from pancreatic surgery. In 
2007, the team conducted a similar 
study that established the seven-day 
“Critical Pathway” standard at Jefferson. 
The WARP trial — initiated in late 2015 
and with nearly 70 patients enrolled 
to date — is testing a five-day pathway. 
The protocol incorporates in-hospital 
physical therapy, specific dietary 
recommendations and rigorous 
monitoring following discharge. 
Meanwhile, Jordan M. Winter, MD, 
FACS, is tackling a perennial patient 
query: “Can pancreatic surgery make 
the cancer ‘spread’?” To explore this 
topic, Dr. Winter is leading the Water 
or Saline at High Volumes (WASH) 
trial that is testing the use of 10 liters of 
plain water or salt water for abdominal 
washing immediately following removal 
of the tumor. Current practice uses 
just one or two liters of saline at the 
conclusion of the procedure. The 
study, started in April 2016 with more 
than 100 patients enrolled to date, 
aims to expand to other sites and 
enroll 800 patients.
For more information, go to 
Jefferson.edu/Pancreas.
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Our multidisciplinary pancreatic cancer team includes surgeons, GI specialists, medical oncologists,  
radiation oncologists, advanced practice nurses, research scientists, residents, postdoc fellows, graduate 
students, clinical research coordinators and nutritionists.
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“In Asia, average hospital stay for pancreatic surgery patients is 21 days. 
In Europe, it’s 14 days. In most U.S. hospitals, it’s 12 to 14 days. Here at 
Jefferson, our current seven-day stay requires tremendous coordination 
across the Surgery, ICU and Nursing teams. With the WARP trial, we are 
trying to do something few others have consistently been able to do: 
improve outcomes by safely discharging Whipple procedure patients 
after just 5 days.
“Why are shorter hospital stays better? Research has shown that being in a hospital when you 
aren’t critically ill actually delays healing and exposes patients to hospital-acquired infections. 
We want to prepare our patients to leave the hospital as quickly as possible so they can recover 
safely and more rapidly in the comfort of their own homes.”
Harish Lavu, MD, FACS 
Associate Professor and Chief, Section of Hepatopancreatobiliary Surgery
“Lymphatics, nerves, small blood vessels and tumor margins frequently 
have cancer in them, which can only be appreciated at the microscopic 
level. As we’re dividing these structures, can some of these cells be 
spilled? It isn’t inconceivable. The hypothesis of the WASH study is that 
this high-volume washing may remove those kinds of free-floating 
cancer cells present after the tumor is resected – ultimately helping to  
prolong survival. 
“Very few surgical cancer studies have looked specifically at pancreatic cancer outcomes.  
This trial points to the potential for surgical oncologists to affect cancer outcomes with an 
inexpensive intervention: high-volume abdominal washing. If we can use it to improve survival 
even by a few months, we’re accomplishing the same thing as a billion-dollar drug.” 
Jordan Winter, MD, FACS 
Associate Professor
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